Small-Dose Bupivacaine-Sufentanil Prevents Cardiac Output Modifications After Spinal Anesthesia

Spinal injection of small-dose (SD) bupivacaine decreases the likelihood of hypotension compared with large-dose (LD) bupivacaine. We assumed that a SD of bupivacaine could also prevent the decrease in cardiac output (CO). Patients undergoing elective urologic, lower abdominal, or lower limb surgery...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Anesthesia and analgesia 2005-11, Vol.101 (5), p.1512-1515
Hauptverfasser: Asehnoune, Karim, Larousse, Eric, Tadié, Jean Marc, Minville, Vincent, Droupy, Stephane, Benhamou, Dan
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1515
container_issue 5
container_start_page 1512
container_title Anesthesia and analgesia
container_volume 101
creator Asehnoune, Karim
Larousse, Eric
Tadié, Jean Marc
Minville, Vincent
Droupy, Stephane
Benhamou, Dan
description Spinal injection of small-dose (SD) bupivacaine decreases the likelihood of hypotension compared with large-dose (LD) bupivacaine. We assumed that a SD of bupivacaine could also prevent the decrease in cardiac output (CO). Patients undergoing elective urologic, lower abdominal, or lower limb surgery under spinal anesthesia were included in this prospective randomized study. Spinal injection consisted of 5 μg of sufentanil and either SD (7.5 mg of hyperbaric bupivacaine with glucosemonohydrate80 mg/mL; n = 19 patients) or LD (12.5 mg of hyperbaric bupivacaine with glucosemonohydrate80 mg/mL; n = 19 patients). CO (impedance cardiography), arterial blood pressure, and heart rate) were measured at 1 min before performance of spinal block and 2, 10, and 30 min after the intrathecal injection. Sensory level was also assessed at 30 min. CO was higher in the SD group as compared with the LD group from 2 min to 30 min after spinal anesthesia. Moreover, CO increased at 2 min in the SD group and decreased at 10 and 30 min in the LD group compared with baseline value. In conclusion, SD bupivacaine provides successful anesthesia and gives better CO stability than LD.
doi_str_mv 10.1213/01.ANE.0000180996.91358.CC
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_68720140</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>68720140</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4446-2dd8b11c31a0830b79ee8ed6b0f7027b8974f966877b4b6bf9b6d9b538d642883</originalsourceid><addsrcrecordid>eNpFkF2P1CAUhonRuOPqXzCNid61coBS8G6s60eyuiaj1wQoZFCm7UK7G_-97M4kQ0IOJM973uRB6A3gBgjQ9xia7Y-rBpcDAkvJGwm0FU3fP0EbaAmvu1aKp2hTAFoTKeUFepHznwceC_4cXQAnjGFCNkjtDjrG-tOUXfVxncOdtjqMrt6t3o2LHkOsfiZ3V9656nUagrbVzbrM61J9n4bgg9VLmMZcbf3iUrWbw6hjtR1dXvYuB_0SPfM6ZvfqNC_R789Xv_qv9fXNl2_99rq2jDFek2EQBsBS0FhQbDrpnHADN9h3mHRGyI55ybnoOsMMN14aPkjTUjFwRoSgl-jdce-cptu1tKtDyNbFqEc3rVmVJMHAcAE_HEGbppyT82pO4aDTPwVYPehVGFTRq8561aNe1fcl_PrUspqDG87Rk88CvD0BOlsdfdKjDfnMdYSBpFA4duTup1i85b9xvXdJ7Z2Oy_6xGrdU1qQMgPKpy2Wc_gfBUpMk</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>68720140</pqid></control><display><type>article</type><title>Small-Dose Bupivacaine-Sufentanil Prevents Cardiac Output Modifications After Spinal Anesthesia</title><source>MEDLINE</source><source>Journals@Ovid LWW Legacy Archive</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Asehnoune, Karim ; Larousse, Eric ; Tadié, Jean Marc ; Minville, Vincent ; Droupy, Stephane ; Benhamou, Dan</creator><creatorcontrib>Asehnoune, Karim ; Larousse, Eric ; Tadié, Jean Marc ; Minville, Vincent ; Droupy, Stephane ; Benhamou, Dan</creatorcontrib><description>Spinal injection of small-dose (SD) bupivacaine decreases the likelihood of hypotension compared with large-dose (LD) bupivacaine. We assumed that a SD of bupivacaine could also prevent the decrease in cardiac output (CO). Patients undergoing elective urologic, lower abdominal, or lower limb surgery under spinal anesthesia were included in this prospective randomized study. Spinal injection consisted of 5 μg of sufentanil and either SD (7.5 mg of hyperbaric bupivacaine with glucosemonohydrate80 mg/mL; n = 19 patients) or LD (12.5 mg of hyperbaric bupivacaine with glucosemonohydrate80 mg/mL; n = 19 patients). CO (impedance cardiography), arterial blood pressure, and heart rate) were measured at 1 min before performance of spinal block and 2, 10, and 30 min after the intrathecal injection. Sensory level was also assessed at 30 min. CO was higher in the SD group as compared with the LD group from 2 min to 30 min after spinal anesthesia. Moreover, CO increased at 2 min in the SD group and decreased at 10 and 30 min in the LD group compared with baseline value. In conclusion, SD bupivacaine provides successful anesthesia and gives better CO stability than LD.</description><identifier>ISSN: 0003-2999</identifier><identifier>EISSN: 1526-7598</identifier><identifier>DOI: 10.1213/01.ANE.0000180996.91358.CC</identifier><identifier>PMID: 16244022</identifier><identifier>CODEN: AACRAT</identifier><language>eng</language><publisher>Hagerstown, MD: International Anesthesia Research Society</publisher><subject>Adult ; Aged ; Anesthesia ; Anesthesia, Spinal - adverse effects ; Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy ; Biological and medical sciences ; Bupivacaine - administration &amp; dosage ; Cardiac Output - drug effects ; Female ; Heart Rate - drug effects ; Humans ; Male ; Medical sciences ; Middle Aged ; Prospective Studies ; Sufentanil - administration &amp; dosage</subject><ispartof>Anesthesia and analgesia, 2005-11, Vol.101 (5), p.1512-1515</ispartof><rights>International Anesthesia Research Society</rights><rights>2005 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4446-2dd8b11c31a0830b79ee8ed6b0f7027b8974f966877b4b6bf9b6d9b538d642883</citedby><cites>FETCH-LOGICAL-c4446-2dd8b11c31a0830b79ee8ed6b0f7027b8974f966877b4b6bf9b6d9b538d642883</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttp://ovidsp.ovid.com/ovidweb.cgi?T=JS&amp;NEWS=n&amp;CSC=Y&amp;PAGE=fulltext&amp;D=ovft&amp;AN=00000539-200511000-00046$$EHTML$$P50$$Gwolterskluwer$$H</linktohtml><link.rule.ids>314,776,780,4594,27903,27904,65210</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=17241931$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16244022$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Asehnoune, Karim</creatorcontrib><creatorcontrib>Larousse, Eric</creatorcontrib><creatorcontrib>Tadié, Jean Marc</creatorcontrib><creatorcontrib>Minville, Vincent</creatorcontrib><creatorcontrib>Droupy, Stephane</creatorcontrib><creatorcontrib>Benhamou, Dan</creatorcontrib><title>Small-Dose Bupivacaine-Sufentanil Prevents Cardiac Output Modifications After Spinal Anesthesia</title><title>Anesthesia and analgesia</title><addtitle>Anesth Analg</addtitle><description>Spinal injection of small-dose (SD) bupivacaine decreases the likelihood of hypotension compared with large-dose (LD) bupivacaine. We assumed that a SD of bupivacaine could also prevent the decrease in cardiac output (CO). Patients undergoing elective urologic, lower abdominal, or lower limb surgery under spinal anesthesia were included in this prospective randomized study. Spinal injection consisted of 5 μg of sufentanil and either SD (7.5 mg of hyperbaric bupivacaine with glucosemonohydrate80 mg/mL; n = 19 patients) or LD (12.5 mg of hyperbaric bupivacaine with glucosemonohydrate80 mg/mL; n = 19 patients). CO (impedance cardiography), arterial blood pressure, and heart rate) were measured at 1 min before performance of spinal block and 2, 10, and 30 min after the intrathecal injection. Sensory level was also assessed at 30 min. CO was higher in the SD group as compared with the LD group from 2 min to 30 min after spinal anesthesia. Moreover, CO increased at 2 min in the SD group and decreased at 10 and 30 min in the LD group compared with baseline value. In conclusion, SD bupivacaine provides successful anesthesia and gives better CO stability than LD.</description><subject>Adult</subject><subject>Aged</subject><subject>Anesthesia</subject><subject>Anesthesia, Spinal - adverse effects</subject><subject>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</subject><subject>Biological and medical sciences</subject><subject>Bupivacaine - administration &amp; dosage</subject><subject>Cardiac Output - drug effects</subject><subject>Female</subject><subject>Heart Rate - drug effects</subject><subject>Humans</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Prospective Studies</subject><subject>Sufentanil - administration &amp; dosage</subject><issn>0003-2999</issn><issn>1526-7598</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpFkF2P1CAUhonRuOPqXzCNid61coBS8G6s60eyuiaj1wQoZFCm7UK7G_-97M4kQ0IOJM973uRB6A3gBgjQ9xia7Y-rBpcDAkvJGwm0FU3fP0EbaAmvu1aKp2hTAFoTKeUFepHznwceC_4cXQAnjGFCNkjtDjrG-tOUXfVxncOdtjqMrt6t3o2LHkOsfiZ3V9656nUagrbVzbrM61J9n4bgg9VLmMZcbf3iUrWbw6hjtR1dXvYuB_0SPfM6ZvfqNC_R789Xv_qv9fXNl2_99rq2jDFek2EQBsBS0FhQbDrpnHADN9h3mHRGyI55ybnoOsMMN14aPkjTUjFwRoSgl-jdce-cptu1tKtDyNbFqEc3rVmVJMHAcAE_HEGbppyT82pO4aDTPwVYPehVGFTRq8561aNe1fcl_PrUspqDG87Rk88CvD0BOlsdfdKjDfnMdYSBpFA4duTup1i85b9xvXdJ7Z2Oy_6xGrdU1qQMgPKpy2Wc_gfBUpMk</recordid><startdate>20051101</startdate><enddate>20051101</enddate><creator>Asehnoune, Karim</creator><creator>Larousse, Eric</creator><creator>Tadié, Jean Marc</creator><creator>Minville, Vincent</creator><creator>Droupy, Stephane</creator><creator>Benhamou, Dan</creator><general>International Anesthesia Research Society</general><general>Lippincott</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20051101</creationdate><title>Small-Dose Bupivacaine-Sufentanil Prevents Cardiac Output Modifications After Spinal Anesthesia</title><author>Asehnoune, Karim ; Larousse, Eric ; Tadié, Jean Marc ; Minville, Vincent ; Droupy, Stephane ; Benhamou, Dan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4446-2dd8b11c31a0830b79ee8ed6b0f7027b8974f966877b4b6bf9b6d9b538d642883</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Anesthesia</topic><topic>Anesthesia, Spinal - adverse effects</topic><topic>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</topic><topic>Biological and medical sciences</topic><topic>Bupivacaine - administration &amp; dosage</topic><topic>Cardiac Output - drug effects</topic><topic>Female</topic><topic>Heart Rate - drug effects</topic><topic>Humans</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Prospective Studies</topic><topic>Sufentanil - administration &amp; dosage</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Asehnoune, Karim</creatorcontrib><creatorcontrib>Larousse, Eric</creatorcontrib><creatorcontrib>Tadié, Jean Marc</creatorcontrib><creatorcontrib>Minville, Vincent</creatorcontrib><creatorcontrib>Droupy, Stephane</creatorcontrib><creatorcontrib>Benhamou, Dan</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Anesthesia and analgesia</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Asehnoune, Karim</au><au>Larousse, Eric</au><au>Tadié, Jean Marc</au><au>Minville, Vincent</au><au>Droupy, Stephane</au><au>Benhamou, Dan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Small-Dose Bupivacaine-Sufentanil Prevents Cardiac Output Modifications After Spinal Anesthesia</atitle><jtitle>Anesthesia and analgesia</jtitle><addtitle>Anesth Analg</addtitle><date>2005-11-01</date><risdate>2005</risdate><volume>101</volume><issue>5</issue><spage>1512</spage><epage>1515</epage><pages>1512-1515</pages><issn>0003-2999</issn><eissn>1526-7598</eissn><coden>AACRAT</coden><abstract>Spinal injection of small-dose (SD) bupivacaine decreases the likelihood of hypotension compared with large-dose (LD) bupivacaine. We assumed that a SD of bupivacaine could also prevent the decrease in cardiac output (CO). Patients undergoing elective urologic, lower abdominal, or lower limb surgery under spinal anesthesia were included in this prospective randomized study. Spinal injection consisted of 5 μg of sufentanil and either SD (7.5 mg of hyperbaric bupivacaine with glucosemonohydrate80 mg/mL; n = 19 patients) or LD (12.5 mg of hyperbaric bupivacaine with glucosemonohydrate80 mg/mL; n = 19 patients). CO (impedance cardiography), arterial blood pressure, and heart rate) were measured at 1 min before performance of spinal block and 2, 10, and 30 min after the intrathecal injection. Sensory level was also assessed at 30 min. CO was higher in the SD group as compared with the LD group from 2 min to 30 min after spinal anesthesia. Moreover, CO increased at 2 min in the SD group and decreased at 10 and 30 min in the LD group compared with baseline value. In conclusion, SD bupivacaine provides successful anesthesia and gives better CO stability than LD.</abstract><cop>Hagerstown, MD</cop><pub>International Anesthesia Research Society</pub><pmid>16244022</pmid><doi>10.1213/01.ANE.0000180996.91358.CC</doi><tpages>4</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0003-2999
ispartof Anesthesia and analgesia, 2005-11, Vol.101 (5), p.1512-1515
issn 0003-2999
1526-7598
language eng
recordid cdi_proquest_miscellaneous_68720140
source MEDLINE; Journals@Ovid LWW Legacy Archive; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals
subjects Adult
Aged
Anesthesia
Anesthesia, Spinal - adverse effects
Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy
Biological and medical sciences
Bupivacaine - administration & dosage
Cardiac Output - drug effects
Female
Heart Rate - drug effects
Humans
Male
Medical sciences
Middle Aged
Prospective Studies
Sufentanil - administration & dosage
title Small-Dose Bupivacaine-Sufentanil Prevents Cardiac Output Modifications After Spinal Anesthesia
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-23T04%3A34%3A55IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Small-Dose%20Bupivacaine-Sufentanil%20Prevents%20Cardiac%20Output%20Modifications%20After%20Spinal%20Anesthesia&rft.jtitle=Anesthesia%20and%20analgesia&rft.au=Asehnoune,%20Karim&rft.date=2005-11-01&rft.volume=101&rft.issue=5&rft.spage=1512&rft.epage=1515&rft.pages=1512-1515&rft.issn=0003-2999&rft.eissn=1526-7598&rft.coden=AACRAT&rft_id=info:doi/10.1213/01.ANE.0000180996.91358.CC&rft_dat=%3Cproquest_cross%3E68720140%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=68720140&rft_id=info:pmid/16244022&rfr_iscdi=true